Inhibition of lysosomal function in macrophages incubated with elevated glucose concentrations: A potential contributory factor in diabetes-associated atherosclerosis-Reference-Cited by-同舟云学术

Inhibition of lysosomal function in macrophages incubated with elevated glucose concentrations: A potential contributory factor in diabetes-associated atherosclerosis

Published:2012-07 Issue:1 Volume:223 Page:144-151
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Moheimani Fatemeh,Kim Christine H.J.,Rahmanto Aldwin Suryo,van Reyk David M.,Davies Michael J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Is hyperglycemia a causal factor in cardiovascular disease? Does proving this relationship really matter? Yes;Davidson;Diabetes Care,2009

2. Innate immunity, macrophage activation, and atherosclerosis;Yan;Immunol Rev,2007

3. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models;Weber;Nat Rev Immunol,2008

4. Advanced atherosclerotic foam cell formation has features of an acquired lysosomal storage disorder;Jerome;Rejuvenation Res,2006

5. Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages;Brown;FEBS J,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cathepsin B in cardiovascular disease: Underlying mechanisms and therapeutic strategies;Journal of Cellular and Molecular Medicine;2024-09

2. Secreted frizzled-related protein 2 ameliorates diabetic cardiomyopathy by activating mitophagy;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

3. Trichomonas vaginalis Legumain-2, TvLEGU-2, Is an Immunogenic Cysteine Peptidase Expressed during Trichomonal Infection;Pathogens;2024-01-27

4. Epigenetically altered macrophages promote development of diabetes-associated atherosclerosis;Frontiers in Immunology;2023-05-05

5. After one year of the COVID-19 pandemic and hundreds of suggested drugs, will cathepsin L inhibitors be the solution?;Avicenna;2021-11-22